The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Single nucleotide polymorphisms and cancer susceptibility
Open accessAbstract
// Na Deng 1, 2 , Heng Zhou 1 , Hua Fan 2 and Yuan Yuan 1, 3 1 Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department, Shenyang 110001, China 2 Department of Hematology, The Fourth Affiliated Hospital of China Medical University, Shenyang 110001, China 3 National Clinical Research Center for Digestive Diseases, Xi’an 110001, China Correspondence to: Yuan Yuan, email: yuanyuan@cmu.edu.cn Keywords: single nucleotide polymorphism, genetic, epigenetic, susceptibility, cancer Received: August 26, 2016 Accepted: October 03, 2017 Published: November 07, 2017 ABSTRACT A large number of genes associated with various cancer types contain single nucleotide polymorphisms (SNPs). SNPs are located in gene promoters, exons, introns as well as 5'- and 3'- untranslated regions (UTRs) and affect gene expression by different mechanisms. These mechanisms depend on the role of the genetic elements in which the individual SNPs are located. Moreover, alterations in epigenetic regulation due to gene polymorphisms add to the complexity underlying cancer susceptibility related to SNPs. In this systematic review, we discuss the various genetic and epigenetic mechanisms involved in determining cancer susceptibility related to various SNPs located in different genetic elements. We also discuss the diagnostic potential of these SNPs and the focus for future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
The role of site accessibility in microRNA target recognition
Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., & Segal, E. (2007) · Nature Genetics · doi:10.1038/ng2135 · Cited by 2,460
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Evolution and functional impact of rare coding variation from deep sequencing of human exomes
Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613
The human splicing code reveals new insights into the genetic determinants of disease
Xiong, H. Y., Alipanahi, B., Lee, L. J., Bretschneider, H., Merico, D., Yuen, R. K. C., Hua, Y., Gueroussov, S., Najafabadi, H. S., Hughes, T. R., et al. (2015) · Science · doi:10.1126/science.1254806 · Cited by 1,220
Mutations driving CLL and their evolution in progression and relapse
Landau, D. A., Tausch, E., Taylor-Weiner, A. N., Stewart, C., Reiter, J. G., Bahlo, J., Kluth, S., Bozic, I., Lawrence, M., Böttcher, S., et al. (2015) · Nature · doi:10.1038/nature15395 · Cited by 1,068
Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., & Diatchenko, L. (2006) · Science · doi:10.1126/science.1131262 · Cited by 848
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
Pomerantz, M. M., Ahmadiyeh, N., Jia, L., Herman, P., Verzi, M. P., Doddapaneni, H., Beckwith, C. A., Chan, J. A., Hills, A., Davis, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.403 · Cited by 663
Regulation of mRNA translation by 5′- and 3′-UTR-binding factors
Wilkie, G. S., Dickson, K. S., & Gray, N. K. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00051-3 · Cited by 512
Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA
Duan, R., Pak, C., & Jin, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm062 · Cited by 497
Kerkel, K., Spadola, A., Yuan, E., Kosek, J., Jiang, L., Hod, E., Li, K., Murty, V. V., Schupf, N., Vilain, E., et al. (2008) · Nature Genetics · doi:10.1038/ng.174 · Cited by 441
Identification of Genetic Variants That Affect Histone Modifications in Human Cells
McVicker, G., van de Geijn, B., Degner, J. F., Cain, C. E., Banovich, N. E., Raj, A., Lewellen, N., Myrthil, M., Gilad, Y., & Pritchard, J. K. (2013) · Science · doi:10.1126/science.1242429 · Cited by 436
Mishra, P. J., Humeniuk, R., Mishra, P. J., Longo-Sorbello, G. S. A., Banerjee, D., & Bertino, J. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706217104 · Cited by 417
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
Zhang, D., Cheng, L., Badner, J. A., Chen, C., Chen, Q., Luo, W., Craig, D. W., Redman, M., Gershon, E. S., & Liu, C. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.02.005 · Cited by 387
Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome
Shoemaker, R., Deng, J., Wang, W., & Zhang, K. (2010) · Genome Research · doi:10.1101/gr.104695.109 · Cited by 380
Hu, Z., Liang, J., Wang, Z., Tian, T., Zhou, X., Chen, J., Miao, R., Wang, Y., Wang, X., & Shen, H. (2009) · Human Mutation · doi:10.1002/humu.20837 · Cited by 380
Rakyan, V. K., Hildmann, T., Novik, K. L., Lewin, J., Tost, J., Cox, A. V., Andrews, T. D., Howe, K. L., Otto, T., Olek, A., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020405 · Cited by 359
Shan, Y., Eastwood, M. P., Zhang, X., Kim, E. T., Arkhipov, A., Dror, R. O., Jumper, J., Kuriyan, J., & Shaw, D. E. (2012) · Cell · doi:10.1016/j.cell.2012.02.063 · Cited by 357
Cowper-Sal·lari, R., Zhang, X., Wright, J. B., Bailey, S. D., Cole, M. D., Eeckhoute, J., Moore, J. H., & Lupien, M. (2012) · Nature Genetics · doi:10.1038/ng.2416 · Cited by 355
Pandey, G. K., Mitra, S., Subhash, S., Hertwig, F., Kanduri, M., Mishra, K., Fransson, S., Ganeshram, A., Mondal, T., Bandaru, S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.014 · Cited by 343
Lubelski, J., Konings, W. N., & Driessen, A. J. M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-07 · Cited by 339
Single-nucleotide polymorphisms can cause different structural folds of mRNA
Shen, L. X., Basilion, J. P., & Stanton, V. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7871 · Cited by 317
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Oldridge, D. A., Wood, A. C., Weichert-Leahey, N., Crimmins, I., Sussman, R., Winter, C., McDaniel, L. D., Diamond, M., Hart, L. S., Zhu, S., et al. (2015) · Nature · doi:10.1038/nature15540 · Cited by 301
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility
Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01737.x · Cited by 286
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice
Raveche, E. S., Salerno, E., Scaglione, B. J., Manohar, V., Abbasi, F., Lin, Y.-C., Fredrickson, T., Landgraf, P., Ramachandra, S., Huppi, K., et al. (2007) · Blood · doi:10.1182/blood-2007-02-071225 · Cited by 281
Silent (Synonymous) SNPs: Should We Care About Them?
Hunt, R., Sauna, Z. E., Ambudkar, S. V., Gottesman, M. M., & Kimchi-Sarfaty, C. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-411-1_2 · Cited by 271
Wright, J. B., Brown, S. J., & Cole, M. D. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01384-09 · Cited by 258
Stirzaker, C., Song, J. Z., Davidson, B., & Clark, S. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3690 · Cited by 240
Yates, C. M., & Sternberg, M. J. E. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.012 · Cited by 238
Zhang, X., Miao, X., Tan, W., Ning, B., Liu, Z., Hong, Y., Song, W., Guo, Y., Zhang, X., Shen, Y., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.003 · Cited by 232
Translational pathophysiology: a novel molecular mechanism of human disease
Cazzola, M., & Skoda, R. C. (2000) · Blood · doi:10.1182/blood.v95.11.3280 · Cited by 223
A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.
Li, L., Chui, R. M., Sasaki, M., Nakajima, K., PERINCHERY, G., Au, H. C., Nojima, D., Carroll, P. R., & Dahiya, R. (2000) · PubMed · Cited by 208
French, J. D., Ghoussaini, M., Edwards, S. L., Meyer, K. B., Michailidou, K., Ahmed, S., Khan, S., Maranian, M. J., O’Reilly, M., Hillman, K. M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.002 · Cited by 207
Yu, C., Zhou, Y., Miao, X., Xiong, P., Tan, W., & Lin, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1521 · Cited by 196
Xu, Y., Liu, L., Liu, J., Zhang, Y., Zhu, J., Chen, J., Liu, S., Liu, Z., Shi, H., Shen, H., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25342 · Cited by 189
Allele-specific DNA methylation: beyond imprinting
Tycko, B. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq376 · Cited by 178
Protein-protein interaction sites are hot spots for disease-associated nonsynonymous SNPs
David, A., Razali, R., Wass, M. N., & Sternberg, M. J. E. (2012) · Human Mutation · doi:10.1002/humu.21656 · Cited by 169
Zhang, X., Zhou, L., Fu, G., Sun, F. Y., Shi, J., Wei, J., Lu, C. T., Zhou, C., Yuan, Q., & Yang, M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu103 · Cited by 156
Brendle, A., Lei, H., Brandt, A., Johansson, R., Enquist, K., Henriksson, R., Hemminki, K., Lenner, P., & Försti, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn126 · Cited by 151
Nielsen, K. B., Sørensen, S., Cartegni, L., Corydon, T. J., Doktor, T. K., Schroeder, L. D., Reinert, L. S., Elpeleg, O. N., Krainer, A. R., Gregersen, N., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511992 · Cited by 150
Sauna, Z. E., & Ambudkar, S. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0155 · Cited by 147
Polymorphisms in the H19 Gene and the Risk of Bladder Cancer
Verhaegh, G. W. C. T., Verkleij, L., Vermeulen, S. H. H. M., den Heijer, M., Witjes, J. A., & Kiemeney, L. A. L. M. (2008) · European Urology · doi:10.1016/j.eururo.2008.01.060 · Cited by 141
Chappell, S. A., Quesne, J. P. C. L., Paulin, F., deSchoolmeester, M. L., Stoneley, M., Soutar, R. L., Ralston, S. H., Helfrich, M., & Willis, A. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203791 · Cited by 138
DeClerck, Y. A., Darville, M. I., Eeckhout, Y., & Rousseau, G. G. (1994) · Gene · doi:10.1016/0378-1119(94)90753-6 · Cited by 111
GUPTA, S. K., Majumdar, S., Bhattacharya, T. K., & Ghosh, T. C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2351 · Cited by 110
Laying a solid foundation for Manhattan – ‘setting the functional basis for the post-GWAS era’
Zhang, X., Bailey, S. D., & Lupien, M. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.02.006 · Cited by 96
Ogino, S., Hazra, A., Tranah, G. J., Kirkner, G. J., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Meyerhardt, J. A., Hunter, D. J., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm160 · Cited by 96
Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants
Pagenstecher, C., Wehner, M., Friedl, W., Rahner, N., Aretz, S., Friedrichs, N., Sengteller, M., Henn, W., Buettner, R., Propping, P., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-0107-8 · Cited by 94
An Insertion/Deletion Polymorphism within RERT-lncRNA Modulates Hepatocellular Carcinoma Risk
Zhu, Z., Gao, X., He, Y., Zhao, H., Yu, Q., Jiang, D., Zhang, P., Ma, X., Huang, H., Dong, D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0010 · Cited by 91
Li, L., Sun, R., Liang, Y., Pan, X.-M., Li, Z., Bai, P., Zeng, X., Zhang, D., Zhang, L., & Gao, L. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-104 · Cited by 89
He, H., Li, W., Liyanarachchi, S., Srinivas, M., Wang, Y., Akagi, K., Wang, Y., Wu, D., Wang, Q., Jin, V. X., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506255112 · Cited by 89
Non‐random usage of ‘degenerate’ codons is related to protein three‐dimensional structure
Adzhubei, A. A., Adzhubeib, I. A., Krasheninnikov, I. A., & Neidle, S. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01287-2 · Cited by 88
Gong, J., Tian, J., Lou, J., Ke, J., Li, L., Li, J., Yang, Y., Gong, Y., Zhu, Y., Zhang, Y., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw024 · Cited by 88
Fan, H., Liu, D., Qiu, X., Qiao, F., Wu, Q.-X., Su, X., Zhang, F., Song, Y., Zhao, Z., & Xie, W. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-12 · Cited by 87
Self-citationArisawa, T., Tahara, T., Shiroeda, H., Matsue, Y., Minato, T., Nomura, T., Yamada, H., Hayashi, R., Saito, T., Matsunaga, K., et al. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.04.011 · Cited by 84
Griseri, P., Bourcier, C., Hiéblot, C., Essafi‐Benkhadir, K., Chamorey, E., Touriol, C., & Pagès, G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr390 · Cited by 77
FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
Campbell, T. M., Castro, M. A. A., de Santiago, I., Fletcher, M. N. C., Halim, S., Prathalingam, R., Ponder, B. A. J., & Meyer, K. B. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw065 · Cited by 73
An Sp1/Sp3 Binding Polymorphism Confers Methylation Protection
Boumber, Y., Kondo, Y., Chen, X., Shen, L., Guo, Y., Tellez, C. S., Estecio, M. R., Ahmed, S., & Issa, J. J. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000162 · Cited by 72
Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site
Ulaganathan, V. K., Sperl, B., Rapp, U. R., & Ullrich, A. (2015) · Nature · doi:10.1038/nature16449 · Cited by 71
Lv, Z., Xu, Q., & Yuan, Y. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.10.002 · Cited by 71
Self-citationGenetic variants in noncoding PIWI‐interacting RNA and colorectal cancer risk
Chu, H., Xia, L., Qiu, X., Gu, D., Zhu, L., Jin, J., Hui, G., Hua, Q., Du, M., Tong, N., et al. (2015) · Cancer · doi:10.1002/cncr.29314 · Cited by 69
Tran, H. T. T., Takeshima, Y., Surono, A., Yagi, M., Wada, H., & Matsuo, M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.03.006 · Cited by 67
Butcher, D. T., Mancini‐DiNardo, D., Archer, T., & Rodenhiser, D. I. (2004) · International Journal of Cancer · doi:10.1002/ijc.20324 · Cited by 66
Zheng, J., Jiang, L., Zhang, L., Yang, L., Deng, J., You, Y., Li, N., Wu, H., Li, W., Lü, J., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs307 · Cited by 65
Lo, P. H. Y., Urabe, Y., Kumar, V., Tanikawa, C., Koike, K., Kato, N., Miki, D., Chayama, K., Kubo, M., Nakamura, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061279 · Cited by 62
Thuy, N. B. T., Ucisik-Akkaya, E., Davis, C. F., Morrison, B. A., & Dorak, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.015 · Cited by 61
Natural variation of histone modification and its impact on gene expression in the rat genomePreprint
Rintisch, C., Heinig, M., Bauerfeind, A., Schäfer, S., Mieth, C., Patone, G., Hummel, O., Chen, W., Cook, S. A., Cuppen, E. P. J. G., et al. (2014) · Genome Research · doi:10.1101/gr.169029.113 · Cited by 59
Visser, M., Palstra, R.-J., & Kayser, M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv029 · Cited by 57
Fra‐1 targets the AP‐1 site/2G single nucleotide polymorphism (ETS site) in the MMP‐1 promoter
Tower, G. B., Coon, C. I., Belguise, K., et al. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03821.x · Cited by 52
Influence of epigenetic modifications of the interleukin‐10 promoter on IL10 gene expression
Larsson, L., Thorbert‐Mros, S., Rymo, L., & Berglundh, T. (2012) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2011.00917.x · Cited by 51
He, C., Tu, H., Sun, L. L., Xu, Q., Li, P., Gong, Y., Dong, N., & Yuan, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt079 · Cited by 50
Self-citationBoidot, R., Végran, F., Jacob, D., Chevrier, S., Cadouot, M., Féron, O., Solary, É., & Lizard‐Nacol, S. (2010) · Oncogene · doi:10.1038/onc.2009.525 · Cited by 46
Li, Y., Beckman, K. B., Caberto, C., Kazma, R., Lum‐Jones, A., Haiman, C. A., Marchand, L. L., Stram, D. O., Saxena, R., & Cheng, I. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136796 · Cited by 46
Larsson, L., Rymo, L., & Berglundh, T. (2010) · Genes and Immunity · doi:10.1038/gene.2009.103 · Cited by 43
Wang, Y., Qiu, C., & Cui, Q. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023545 · Cited by 41
Chromatin interactions and candidate genes at ten prostate cancer risk loci
Du, M., Tillmans, L. S., Gao, J., Gao, P. H., Yuan, T., Dittmar, R. L., Song, W., Yang, Y., Sahr, N. A., Wang, T., et al. (2016) · Scientific Reports · doi:10.1038/srep23202 · Cited by 40
Yang, L., Yang, X., Ji, W., Deng, J., Qiu, F., Yang, R., Fang, W., Zhang, L., Huang, D., Xie, C., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1355oc · Cited by 39
Zhu, X. M., Zhang, J., Fan, W., Wang, F., Yao, H., Wang, Z., Hou, S., Tian, Y., Fu, W., Xie, D., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt061 · Cited by 39
Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of gastric cancer
Li, L., Fu, J., Bai, P., Liang, Y., Sun, R., Yuan, F., Zhang, L., & Gao, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3750-2 · Cited by 39
Relevance of Sp Binding Site Polymorphism inWWOXfor Treatment Outcome in Pancreatic Cancer
Schirmer, M., Lüske, C. M., Roppel, S., Schaudinn, A., Zimmer, C., Pflüger, R., Haubrock, M., Rapp, J., Güngör, C., Bockhorn, M., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv387 · Cited by 38
The micro RNA target paradigm: a fundamental and polymorphic control layer of cellular expression
Barnes, M. R., Deharo, S., Grocock, R., Brown, J. R., & Sanséau, P. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.9.1387 · Cited by 35
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: A meta-analysis
Jing, J., Li, M., & Yuan, Y. (2012) · Gene · doi:10.1016/j.gene.2012.03.045 · Cited by 35
Self-citationLiu, J., He, C., Xing, C., & Yuan, Y. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.04.008 · Cited by 34
Self-citationSabarinathan, R., Wenzel, A., Novotny, P., Tang, X., Kalari, K. R., & Gorodkin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082699 · Cited by 33
達彦, 鈴., 和夫, 石., Zhao, X., Wu, W., Wang, H., Lu, J., Wu, Q., Chen, X., Fan, W., Chen, H., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq089 · Cited by 31
He, C., Tu, H., Sun, L. L., Xu, Q., Gong, Y., Jing, J., Dong, N., & Yuan, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4231 · Cited by 30
Self-citationAouacheria, A., Navratil, V., López‐Pérez, R., Gutierrez, N. C., Churkin, A., Barash, D., Mouchiroud, D., & Gautier, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-2 · Cited by 28
Zhang, L., Liang, W., Gao, L., Li, H., Li, L., Chen, P., Liu, Y., Chen, T., Han, J.-G., Wei, Y., et al. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1326 · Cited by 27
Wu, H., Zhang, K., Gong, P., Qiao, F., Wang, L., Cui, H., Sui, X., Gao, J., & Fan, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092911 · Cited by 27
Self-citationFang, W., Qiu, F., Zhang, L., Deng, J., Zhang, H., Yang, L., Zhou, Y., & Lü, J. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.07.009 · Cited by 25
Xu, M. J., Gao, Y., Yu, T., Wang, J., Cheng, L., Cheng, L., Cheng, D., & Zhu, B. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.12.045 · Cited by 24
Xu, Q., Liu, J., He, C., Sun, L. L., Gong, Y., Jing, J., Xing, C., & Yuan, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089203 · Cited by 23
Self-citationShiao, Y., Lupascu, S. T., Gu, Y., Kasprzak, W. K., Hwang, C. J., Fields, J. R., Leighty, R. M., Quiñones, O. A., Shapiro, B. A., Alvord, W. G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007505 · Cited by 23
Xu, Q., Chen, M.-Y., He, C., Sun, L. L., & Yuan, Y. (2013) · Gene · doi:10.1016/j.gene.2013.07.070 · Cited by 23
Self-citationStructural investigation of deleterious non-synonymous SNPs of EGFR gene
Raghav, D., Sharma, V., & Agarwal, S. M. (2013) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-013-0149-x · Cited by 20
He, C., Xu, Q., Tu, H., Sun, L. L., Gong, Y., Liu, J., & Yuan, Y. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22305 · Cited by 19
Self-citationMitochondrial A12308G alteration in tRNALeu(CUN) in colorectal cancer samples
Mohammed, F., Rezaee-Khorasany, A., Mosaieby, E., & Houshmand, M. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0337-6 · Cited by 19
Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population
Cao, D.-L., Gu, C.-Y., Zhu, Y., Dai, B., Zhang, H.-L., Shi, G.-H., Shen, Y., Zhu, Y.-P., Ma, C.-G., Xiao, W.-J., et al. (2014) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2014.34 · Cited by 19
Fan, Q., He, J.-F., Wang, Q., CAI, H.-B., Sun, X., Zhou, X., Qin, H.-D., Shugart, Y. Y., & Jia, W.-H. (2013) · Oncology Reports · doi:10.3892/or.2013.2421 · Cited by 18
The DNA Repair Gene ERCC6 rs1917799 Polymorphism is Associated with Gastric Cancer Risk in Chinese
Liu, J., He, C., Sun, L. L., Xu, Q., Xing, C., & Yuan, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.6103 · Cited by 18
Self-citationTsirka, T., Boukouvala, S., Agianian, B., & Fakis, G. (2013) · Gene · doi:10.1016/j.gene.2013.11.085 · Cited by 16
Role of the functional variant (−652T>G) in the XRCC4 promoter in prostate cancer
Shao, N., Li, J., Xu, B., Wang, Y., Lu, X., & Feng, N. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3636-1 · Cited by 16
Robbez‐Masson, L., Bödör, C., Jones, J. L., Hurst, H. C., Fitzgibbon, J., Hart, I. R., & Grose, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078839 · Cited by 15
Dunna, N. R., Naushad, S. M., Vuree, S., Cingeetham, A., Kagita, S., Damineni, S., Rao, D. R., & Vishnupriya, S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.4.1719 · Cited by 15
Yang, Z.-H., Zhou, C., Zhu, H., Li, J., & He, C. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3817 · Cited by 7
(2000) · PubMed
Cited by
Kim, K. T., & Winssinger, N. (2020) · Chemical Science · doi:10.1039/d0sc00741b · Cited by 17
Almawi, W. Y., Zidi, S., Sghaier, I., El-Ghali, R. M., Daldoul, A., & Midlenko, A. (2023) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.12.017 · Cited by 13
Metadata
- Authors
- Deng, N., Zhou, H., Fan, H., & Yuan, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-11-07
- Volume
- 8
- Issue
- 66
- Pages
- 110635-110649
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2767228538
- Cited by
- 381
- References
- 109
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.